Skip to main content

Advertisement

Table 3 Multivariate Cox Regression Survival Analysis with Dichotomised Scored Monocyte IL-6 Secretion (serum-free medium) Adjusted for Gender and Age (upper panel), or adjusted for Gender, Age and TN stage (lower panel) of HNSCC Patients

From: Stimulated monocyte IL-6 secretion predicts survival of patients with head and neck squamous cell carcinoma

  Total survival Disease-specific survival
  HR 95% CI (HR) P value HR 95% CI (HR) P value
Gender 0.52 0.18–1.52 0.236 0.35 0.10–1.31 0.119
Age 1.07 1.02–1.11 0.002 1.08 1.03–1.28 0.002
IL-6 2.27 1.05–4.88 0.036 2.68 1.11–6.45 0.028
Gender 0.54 0.20–1.50 0.237 0.40 0.11–1.41 0.153
Age 1.06 1.02–1.11 0.008 1.06 1.01–1.11 0.025
T stage 1.64 1.18–2.29 0.003 1.89 1.29–2.79 0.001
N stage 1.55 1.06–2.28 0.025 1.61 1.03–2.51 0.035
IL-6 2.08 0.97–4.48 0.061 2.44 1.01–5.92 0.049
  1. HR = Hazard ratio 95% CI(HR) = 95% confidence interval for HR